767533617	767533617	CD	B-NP	O
|	|	NN	I-NP	O
VSTMC	VSTMC	NN	I-NP	O
|	|	NN	I-NP	O
13291947	13291947	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6398655	6398655	CD	B-NP	O
|	|	CC	I-NP	O
3/10/2005	3/10/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CONGESTIVE	CONGESTIVE	NNP	I-NP	I-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/29/2005	8/29/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/15/2005	2/15/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
VANDERBIE	VANDERBIE	NNP	B-NP	O
,	,	,	O	O
SEBASTIAN	SEBASTIAN	NNP	B-NP	O
J.	J.	NNP	I-NP	O
MD	MD	NNP	I-NP	O
,	,	,	O	O
PHD	PHD	NNP	B-NP	O
ADDENDUM	ADDENDUM	NNP	I-NP	O
Please	Please	NNP	I-NP	O
note	note	NN	I-NP	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
addendum	addendum	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
dictated	dictate	VBN	I-NP	O
discharge	discharge	NN	I-NP	O
summary	summary	NN	I-NP	O
#	#	#	B-NP	O
6047544	6047544	CD	I-NP	O
.	.	.	O	O

INTERIM	INTERIM	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
the	the	DT	B-NP	O
interim	interim	NN	I-NP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
dictated	dictate	VBN	I-NP	O
discharge	discharge	NN	I-NP	O
summary	summary	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
progress	progress	VB	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
by	by	IN	B-PP	O
system	system	NN	B-NP	O
from	from	IN	B-PP	O
10/25/05	10/25/05	CD	B-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
date	date	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
is	be	VBZ	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
remain	remain	VB	I-VP	O
stable	stable	JJ	B-ADJP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
ischemia	ischemia	NN	I-NP	O
standpoint	standpoint	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continues	continue	VBZ	B-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
statin	statin	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
added	add	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
elevated	elevated	JJ	I-NP	O
creatinine	creatinine	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continues	continue	VBZ	B-VP	O
on	on	IN	B-PP	O
Isordil	Isordil	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
and	and	CC	O	O
hydralazine	hydralazine	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
for	for	IN	B-PP	O
after	after	IN	B-PP	O
load	load	NN	B-NP	O
reduction	reduction	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
low-dose	low-dose	JJ	I-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
at	at	IN	B-PP	O
12.5	12.5	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
digoxin	digoxin	NN	B-NP	O
at	at	IN	B-PP	O
0.125	0.125	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.o.d.	q.o.d.	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
aggressively	aggressively	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
Lasix	Lasix	NN	I-NP	O
and	and	CC	I-NP	O
Zaroxolyn	Zaroxolyn	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
conversion	conversion	NN	B-NP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
with	with	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Rayford	Rayford	NNP	I-NP	O
Hogenmiller	Hogenmiller	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Clevesa	Clevesa	NNP	I-NP	O
Irvca	Irvca	NNP	I-NP	O
Sideenandri	Sideenandri	NNP	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
CHF	CHF	NNP	I-NP	O
Service	Service	NNP	I-NP	O
at	at	IN	B-PP	O
Sher-ship	Sher-ship	NNP	B-NP	O
Rimark	Rimark	NNP	I-NP	O
's	's	POS	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
nearing	near	VBG	I-VP	O
euvolemia	euvolemia	NN	B-NP	O
with	with	IN	B-PP	O
estimated	estimate	VBN	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
76	76	CD	I-NP	O
to	to	TO	I-NP	O
77	77	CD	I-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
to	to	TO	B-PP	O
110	110	CD	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
more	more	RBR	B-NP	O
rapid	rapid	JJ	I-NP	O
dysrhythmia	dysrhythmia	NN	I-NP	O
following	follow	VBG	B-PP	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
beta-blocker	beta-blocker	NN	B-NP	O
and	and	CC	I-NP	O
digoxin	digoxin	NN	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
medication	medication	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
continues	continue	VBZ	B-VP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
at	at	IN	B-PP	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
atrial	atrial	JJ	B-NP	O
clot	clot	NN	I-NP	O
on	on	IN	B-PP	O
transesophageal	transesophageal	JJ	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
and	and	CC	O	O
thus	thus	RB	B-ADVP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
heparin	heparin	NN	I-NP	O
drip	drip	NN	I-NP	O
and	and	CC	O	O
transitioned	transitione	VBN	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
substantial	substantial	JJ	I-NP	O
discussion	discussion	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Congestive	Congestive	NNP	I-NP	O
Heart	Heart	NNP	I-NP	O
Failure	Failure	NNP	I-NP	O
Service	Service	NNP	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
outpatient	outpatient	NN	I-NP	O
CHF	CHF	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Team	Team	NNP	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
risks	risk	NNS	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
who	who	WP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
significant	significant	JJ	B-NP	O
noncompliance	noncompliance	NN	I-NP	O
were	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
known	known	JJ	I-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
thromboembolic	thromboembolic	JJ	B-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
known	known	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
clot	clot	NN	I-NP	O
and	and	CC	O	O
thus	thus	RB	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
.	.	.	O	O

Rather	Rather	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
Plavix	Plavix	NN	I-NP	O
at	at	IN	B-PP	O
full	full	JJ	B-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
re-evaluated	re-evaluate	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
follow-up	follow-up	NN	I-NP	O
as	as	IN	B-SBAR	O
deemed	deem	VBN	B-VP	O
appropriate	appropriate	JJ	B-ADJP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
providers	provider	NNS	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
on	on	IN	B-PP	O
stable	stable	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
5	5	CD	I-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
and	and	CC	O	O
standing	stand	VBG	B-VP	O
NovoLog	NovoLog	NNP	B-NP	O
3	3	CD	I-NP	O
units	unit	NNS	I-NP	O
q.a.c.	q.a.c.	VBP	B-VP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
NovoLog	NovoLog	NNP	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
adjusted	adjust	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
and	and	CC	O	O
possibly	possibly	RB	B-NP	O
oral	oral	JJ	I-NP	O
diabetes	diabetes	NN	I-NP	O
medications	medication	NNS	I-NP	O
restarted	restart	VBD	B-VP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
pulmonary	pulmonary	NN	I-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturations	saturation	NNS	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
and	and	CC	O	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
was	be	VBD	B-VP	O
1.6	1.6	CD	B-NP	O
improved	improve	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
peak	peak	NN	I-NP	O
of	of	IN	B-PP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
toxic	toxic	JJ	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
avoided	avoid	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
done	do	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
as	as	IN	B-PP	O
his	his	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
stabilizes	stabilize	VBZ	B-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
were	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
and	and	CC	O	O
repleted	replete	VBN	B-VP	O
aggressively	aggressively	RB	B-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Hematology	Hematology	NN	B-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
not	not	RB	O	O
to	to	TO	B-VP	O
anticoagulate	anticoagulate	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
Plavix	Plavix	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
platelets	platelet	NNS	B-NP	B-cell_type
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
heparin	heparin	NN	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
and	and	CC	O	O
thus	thus	RB	B-NP	O
anti-P4	anti-P4	JJ	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
test	test	NN	I-NP	O
is	be	VBZ	B-VP	O
pending	pende	VBG	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
dictation	dictation	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
outpatient	outpatient	NN	I-NP	O
providers	provider	NNS	I-NP	O
as	as	IN	B-SBAR	O
it	it	PRP	B-NP	O
may	may	MD	B-VP	O
input	input	VB	I-VP	O
further	further	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
meantime	meantime	NN	I-NP	O
,	,	,	O	O
recommend	recommend	VB	B-VP	O
no	no	DT	B-NP	O
heparin	heparin	NN	I-NP	B-protein
products	product	NNS	I-NP	I-protein
.	.	.	O	O

As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
CHF	CHF	NN	I-NP	O
Team	Team	NN	I-NP	O
who	who	WP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
following	follow	VBG	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
not	not	RB	O	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
Coumadin	Coumadin	NN	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
of	of	IN	B-PP	O
5/2/05	5/2/05	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
left-sided	left-sided	JJ	B-NP	O
blurry	blurry	NN	I-NP	O
vision	vision	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
new	new	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
chronic	chronic	JJ	B-NP	O
right	right	JJ	I-NP	O
visual	visual	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
light	light	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
known	know	VBN	I-NP	O
peripheral	peripheral	JJ	I-NP	O
atherosclerotic	atherosclerotic	JJ	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
atrial	atrial	JJ	B-NP	O
clot	clot	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Stroke	Stroke	NNP	I-NP	O
Team	Team	NNP	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
stroke	stroke	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
MRI	MRI	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
show	show	VB	I-VP	O
multiple	multiple	JJ	B-NP	O
old	old	JJ	I-NP	O
infarcts	infarct	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
frontal	frontal	JJ	I-NP	O
,	,	,	I-NP	O
right	right	JJ	I-NP	O
occipital	occipital	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
occipitoparietal	occipitoparietal	JJ	B-ADJP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
posterior	posterior	JJ	B-NP	O
frontal	frontal	JJ	I-NP	O
areas	area	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
new	new	JJ	I-NP	O
stroke	stroke	NN	I-NP	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
MRI	MRI	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
left	left	JJ	I-NP	O
internal	internal	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
artery	artery	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
evaluated	evaluate	VBN	I-VP	O
,	,	,	O	O
not	not	RB	B-VP	O
visualized	visualize	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
MRI	MRI	NN	I-NP	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
left	left	JJ	B-NP	O
carotid	carotid	JJ	I-NP	O
artery	artery	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
versus	versus	IN	B-PP	O
stenosis	stenosis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
declined	decline	VBD	B-VP	O
any	any	DT	B-NP	O
procedure	procedure	NN	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
carotid	carotid	JJ	B-NP	O
endarterectomy	endarterectomy	NN	I-NP	O
or	or	CC	I-NP	O
carotid	carotid	NN	I-NP	O
stenting	stente	VBG	B-VP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
possible	possible	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
and	and	CC	O	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
denial	denial	NN	I-NP	O
no	no	DT	B-NP	O
workup	workup	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
CTA	CTA	NN	I-NP	B-protein
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
because	because	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
decline	decline	VB	I-VP	O
any	any	DT	B-NP	O
intervention	intervention	NN	I-NP	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
contrast	contrast	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
would	would	MD	B-VP	O
outweigh	outweigh	VB	I-VP	O
the	the	DT	B-NP	O
benefits	benefit	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
declined	decline	VBD	B-VP	O
any	any	DT	B-NP	O
intervention	intervention	NN	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
carotid	carotid	NN	I-NP	O
arteries	artery	NNS	I-NP	O
on	on	IN	B-PP	O
several	several	JJ	B-NP	O
occasions	occasion	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
carotid	carotid	JJ	I-NP	O
noninvasives	noninvasive	NNS	I-NP	O
were	be	VBD	B-VP	O
ordered	order	VBN	I-VP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
severity	severity	NN	I-NP	O
of	of	IN	B-PP	O
disease	disease	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Social	Social	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
sister	sister	NN	I-NP	O
,	,	,	O	O
Alexis	Alexis	NNP	B-NP	O
Fernendez	Fernendez	NNP	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
his	his	PRP$	B-NP	O
health	health	NN	I-NP	O
care	care	NN	I-NP	O
proxy	proxy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
presence	presence	NN	I-NP	O
has	have	VBZ	B-VP	O
declined	decline	VBN	I-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
grafting	grafting	NN	B-NP	O
and	and	CC	I-NP	O
heart	heart	NN	I-NP	O
transplant	transplant	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
declined	decline	VBD	I-VP	O
further	further	JJ	B-NP	O
procedure	procedure	NN	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
probable	probable	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Disposition	Disposition	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Com	Com	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Kyle	Kyle	NNP	I-NP	O
Yandle	Yandle	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	O
Las	Las	NNP	I-NP	O
on	on	IN	B-PP	O
8/23/05	8/23/05	CD	B-NP	O
at	at	IN	B-PP	O
08	08	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
a.m.	a.m.	RB	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Clyde	Clyde	NNP	I-NP	O
Chatampaya	Chatampaya	NNP	I-NP	O
of	of	IN	B-PP	O
Elmert	Elmert	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
Cardiology	Cardiology	NNP	I-NP	O
10/25/05	10/25/05	CD	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
TRISTONTERN	TRISTONTERN	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
CENTER	CENTER	NNP	I-NP	O
PCP	PCP	NNP	I-NP	O
,	,	,	O	O
Raymond	Raymond	NNP	B-NP	O
Banaag	Banaag	NNP	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
8/26/05	8/26/05	CD	B-NP	O
at	at	IN	B-PP	O
01	01	CD	B-NP	O
:	:	:	O	O
50	50	CD	B-NP	O
p.m.	p.m.	RB	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
requires	require	VBZ	B-VP	O
substantial	substantial	JJ	B-NP	O
social	social	JJ	I-NP	O
support	support	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
provided	provide	VBN	I-VP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
sister	sister	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	IN	B-PP	O
THE	THE	DT	B-NP	O
TIME	TIME	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Amiodarone	Amiodarone	NN	B-NP	B-protein
200	200	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.o.d.	q.o.d.	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Folate	Folate	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

Robitussin	Robitussin	NN	B-NP	O
A-C	A-C	NN	I-NP	O
5	5	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	JJ	B-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Hydralazine	Hydralazine	NN	B-NP	B-protein
50	50	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

Isordil	Isordil	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Simethicone	Simethicone	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.i.d.	q.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
upset	upset	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	O
one	one	CD	I-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Compazine	Compazine	NN	B-NP	O
5-10	5-10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
nausea	nausea	NN	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Tessalon	Tessalon	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Torsemide	Torsemide	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

Lipitor	Lipitor	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
17	17	CD	I-NP	O
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
5	5	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
18	18	CD	I-NP	O
.	.	.	O	O

NovoLog	NovoLog	NN	B-NP	O
3	3	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
a.c.	a.c.	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
only	only	RB	B-SBAR	O
if	if	IN	I-SBAR	O
food	food	NN	B-NP	O
in	in	IN	B-PP	O
room	room	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
eating	eating	NN	I-NP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
n.p.o.	n.p.o.	NN	B-NP	O
19	19	CD	I-NP	O
.	.	.	O	O

NovoLog	NovoLog	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
please	please	NN	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
give	give	VB	I-VP	O
any	any	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
coverage	coverage	NN	I-NP	O
at	at	IN	B-PP	O
h.s.	h.s.	NN	B-NP	O
but	but	CC	O	O
do	do	VBP	B-VP	O
record	record	VB	I-VP	O
fingerstick	fingerstick	JJ	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
at	at	IN	B-PP	O
h.s.	h.s.	NN	B-NP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
n.p.o.	n.p.o.	NN	B-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
8-7189726	8-7189726	CD	B-NP	O
CS	CS	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
JANISZEWSKI	JANISZEWSKI	NNP	B-NP	O
,	,	,	O	O
TRAVIS	TRAVIS	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
INNES	INNES	NNP	B-NP	O
,	,	,	O	O
BRITT	BRITT	NNP	B-NP	O
P.	P.	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
8506619	8506619	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
5/14/05	5/14/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/14/05	5/14/05	CD	B-NP	O

